Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gasparini

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
Alcoholism, Clinical and Experimental Research|June 1, 1986
Relationship between serum cortisol, liver function, and depression in detoxified alcoholicsM A Zern, U Halbreich, K Bacon, et al.
European Journal of Pharmacology|June 14, 2000
Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout miceW P Spooren, F Gasparini, H van der Putten, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1989
Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short statureM E Markowitz, J DiMartino-Nardi, F Gasparini, et al.
Archivio Stomatologico|July 1, 1973
[Current knowledge on the etiology of periodontosis. Therapeutic considerations]R Bandettini, U Bar, V de Mola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Intraoperative mapping of the cortical areas involved in multiplication and subtraction: an electrostimulation study in a patient with a left parietal gliomaH Duffau, D Denvil, M Lopes, et al.
British Journal of Pharmacology|March 27, 2001
Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonistE Tatarczyńska, A Klodzińska, E Chojnacka-Wójcik, et al.
Biological Psychiatry|December 1, 1986
Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisolU Halbreich, S Naor, G Asnis, et al.
Neuroscience|March 23, 2010
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesiasB Ouattara, D Hoyer, L Grégoire, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group IIIL Amori, G Costantino, M Marinozzi, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
(+)-4-phosphonophenylglycine (PPG) a new group III selective metabotropic glutamate receptor agonistF Gasparini, W Inderbitzin, E Francotte, et al.
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
Alcoholism, Clinical and Experimental Research|June 1, 1986
Relationship between serum cortisol, liver function, and depression in detoxified alcoholicsM A Zern, U Halbreich, K Bacon, et al.
European Journal of Pharmacology|June 14, 2000
Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout miceW P Spooren, F Gasparini, H van der Putten, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1989
Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short statureM E Markowitz, J DiMartino-Nardi, F Gasparini, et al.
Archivio Stomatologico|July 1, 1973
[Current knowledge on the etiology of periodontosis. Therapeutic considerations]R Bandettini, U Bar, V de Mola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Intraoperative mapping of the cortical areas involved in multiplication and subtraction: an electrostimulation study in a patient with a left parietal gliomaH Duffau, D Denvil, M Lopes, et al.
British Journal of Pharmacology|March 27, 2001
Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonistE Tatarczyńska, A Klodzińska, E Chojnacka-Wójcik, et al.
Biological Psychiatry|December 1, 1986
Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisolU Halbreich, S Naor, G Asnis, et al.
Neuroscience|March 23, 2010
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesiasB Ouattara, D Hoyer, L Grégoire, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group IIIL Amori, G Costantino, M Marinozzi, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
(+)-4-phosphonophenylglycine (PPG) a new group III selective metabotropic glutamate receptor agonistF Gasparini, W Inderbitzin, E Francotte, et al.
Pageof 36